1. Home
  2. BQ vs BMRA Comparison

BQ vs BMRA Comparison

Compare BQ & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Boqii Holding Limited representing

BQ

Boqii Holding Limited representing

N/A

Current Price

$0.50

Market Cap

7.7M

ML Signal

N/A

Logo Biomerica Inc.

BMRA

Biomerica Inc.

N/A

Current Price

$1.71

Market Cap

8.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BQ
BMRA
Founded
2008
1971
Country
China
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7M
8.5M
IPO Year
2020
1995

Fundamental Metrics

Financial Performance
Metric
BQ
BMRA
Price
$0.50
$1.71
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 37.1K
10.6K
Earning Date
07-13-2026
10-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 39.81
EPS
★ N/A
N/A
Revenue
N/A
★ $4,453,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.45
$1.45
52 Week High
$4.05
$2.94

Technical Indicators

Market Signals
Indicator
BQ
BMRA
Relative Strength Index (RSI) 20.15 40.59
Support Level $0.45 $1.50
Resistance Level $0.89 $2.23
Average True Range (ATR) 0.05 0.10
MACD -0.00 0.01
Stochastic Oscillator 11.99 45.34

Price Performance

Historical Comparison
BQ
BMRA

About BQ Boqii Holding Limited representing

Boqii Holding Ltd is a pet-focused platform in China. It offer a truly one-stop destination that pet parents in China may go to get everything it need for their pets and share their passion for pet parenting. It operate a pet-focused online retail business in China's pet market in terms of GMV. The company operates in single segment. This segment is engaged in pet products sales and online marketing and information services and other. All the company's revenues is derived from The PRC.

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America generating key revenue from North American Markets.

Share on Social Networks: